253 related articles for article (PubMed ID: 20387990)
21. Process optimization for continuous extrusion wet granulation.
Tan L; Carella AJ; Ren Y; Lo JB
Pharm Dev Technol; 2011 Aug; 16(4):302-15. PubMed ID: 20367553
[TBL] [Abstract][Full Text] [Related]
22. Development of a fluid bed granulation design space using critical quality attribute weighted tolerance intervals.
Zacour BM; Drennen JK; Anderson CA
J Pharm Sci; 2012 Aug; 101(8):2917-29. PubMed ID: 22570275
[TBL] [Abstract][Full Text] [Related]
23. Study of granule growth kinetics during in situ fluid bed melt granulation using in-line FBRM and SFT probes.
Kukec S; Hudovornik G; Dreu R; Vrečer F
Drug Dev Ind Pharm; 2014 Jul; 40(7):952-9. PubMed ID: 23662716
[TBL] [Abstract][Full Text] [Related]
24. Drug distribution in wet granulation: foam versus spray.
Tan MX; Nguyen TH; Hapgood KP
Drug Dev Ind Pharm; 2013 Sep; 39(9):1389-400. PubMed ID: 23057532
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of some compression aids in tableting of roller compacted swellable core drug layer.
Golchert D; Bines E; Carmody A
Int J Pharm; 2013 Sep; 453(2):322-8. PubMed ID: 23796839
[TBL] [Abstract][Full Text] [Related]
26. The effects of using different grades of PVP and gelatin as binders in the fluidized bed granulation and tabletting of lactose.
Georgakopoulos PP; Malamataris S; Dolamidis G
Pharmazie; 1983 Apr; 38(4):240-3. PubMed ID: 6867086
[TBL] [Abstract][Full Text] [Related]
27. Continuous twin screw granulation: influence of process variables on granule and tablet quality.
Vercruysse J; Córdoba Díaz D; Peeters E; Fonteyne M; Delaet U; Van Assche I; De Beer T; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2012 Sep; 82(1):205-11. PubMed ID: 22687571
[TBL] [Abstract][Full Text] [Related]
28. Critical evaluation of root causes of the reduced compactability after roll compaction/dry granulation.
Mosig J; Kleinebudde P
J Pharm Sci; 2015 Mar; 104(3):1108-18. PubMed ID: 25558976
[TBL] [Abstract][Full Text] [Related]
29. Powder flow in an automated uniaxial tester and an annular shear cell: a study of pharmaceutical excipients and analytical data comparison.
Kuentz M; Schirg P
Drug Dev Ind Pharm; 2013 Sep; 39(9):1476-83. PubMed ID: 23043592
[TBL] [Abstract][Full Text] [Related]
30. Investigating the effect of particle size and shape on high speed tableting through radial die-wall pressure monitoring.
Abdel-Hamid S; Alshihabi F; Betz G
Int J Pharm; 2011 Jul; 413(1-2):29-35. PubMed ID: 21515348
[TBL] [Abstract][Full Text] [Related]
31. A microcrystalline cellulose based drug-composite formulation strategy for developing low dose drug tablets.
Sun WJ; Sun CC
Int J Pharm; 2020 Jul; 585():119517. PubMed ID: 32526333
[TBL] [Abstract][Full Text] [Related]
32. Attribute transmission and effects of diluents and granulation liquids on granule properties and tablet quality for high shear wet granulation and tableting process.
Wang L; Zhao L; Hong Y; Shen L; Lin X
Int J Pharm; 2023 Jul; 642():123177. PubMed ID: 37364781
[TBL] [Abstract][Full Text] [Related]
33. Roll compaction/dry granulation: Suitability of different binders.
Mangal H; Kirsolak M; Kleinebudde P
Int J Pharm; 2016 Apr; 503(1-2):213-9. PubMed ID: 26976499
[TBL] [Abstract][Full Text] [Related]
34. [Tableting technology of a dry extract from Solidago virgaurea L. with the use of silicified microcrystalline cellulose (Prosolv) and other selected auxiliary substances].
Marczyiński Z
Polim Med; 2009; 39(4):51-60. PubMed ID: 20099736
[TBL] [Abstract][Full Text] [Related]
35. Understanding the Factors That Control the Quality of Mini-Tablet Compression: Flow, Particle Size, and Tooling Dimension.
Zhao J; Yin D; Rowe J; Badawy S; Nikfar F; Pandey P
J Pharm Sci; 2018 Apr; 107(4):1204-1208. PubMed ID: 29233726
[TBL] [Abstract][Full Text] [Related]
36. Tabletability Modulation Through Surface Engineering.
Osei-Yeboah F; Sun CC
J Pharm Sci; 2015 Aug; 104(8):2645-8. PubMed ID: 26059496
[TBL] [Abstract][Full Text] [Related]
37. Real-time assessment of critical quality attributes of a continuous granulation process.
Fonteyne M; Vercruysse J; Díaz DC; Gildemyn D; Vervaet C; Remon JP; De Beer T
Pharm Dev Technol; 2013 Feb; 18(1):85-97. PubMed ID: 22023327
[TBL] [Abstract][Full Text] [Related]
38. Effects of Particle Surface Roughness on In-Die Flow and Tableting Behavior of Lactose.
Tay JYS; Kok BWT; Liew CV; Heng PWS
J Pharm Sci; 2019 Sep; 108(9):3011-3019. PubMed ID: 31054886
[TBL] [Abstract][Full Text] [Related]
39. Development of potential novel cushioning agents for the compaction of coated multi-particulates by co-processing micronized lactose with polymers.
Lin X; Chyi CW; Ruan KF; Feng Y; Heng PW
Eur J Pharm Biopharm; 2011 Oct; 79(2):406-15. PubMed ID: 21458566
[TBL] [Abstract][Full Text] [Related]
40. Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets.
Liew KB; Hii SH; Chew YL; Ming LC; Uddin AH; Sarker ZI
Int J Pharm Compd; 2022; 26(3):255-263. PubMed ID: 35657749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
